2024    2023    2022    2021    2020    2019    2018    2017    2016   

2019

Articles

91 - 

Arterial Doppler waveform analysis detects more PAD patients in diabetes type 2 but is arterial Doppler waveform analysis standardized?

D. Lanéelle, O. Stivalet, L. Omarjee, G Mahé

Primary Care Diabetes, 2019, 13 (2), pp.189-191.

DOI : https://doi.org/10.1016/j.pcd.2018.11.002

Pubmed : 30545794

 

92 - 

Vascular medicine residents lack adequate training for limb pressure measurement: A nationwide survey in France

Damien Lanéelle, Clement Hoffmann, Olivier Stivalet, Loukman Omarjee, Guillaume Mahé et al.

Vascular Medicine, 2019, 24 (5), pp.452-454.

DOI : https://doi.org/10.1177/1358863X19867759

Pubmed : 31441392

 

93 - 

Description of Doppler waveforms to detect lower extremity peripheral artery disease

Damien Lanéelle, Olivier Stivalet, Guillaume Mahé, Vincent Jaquinandi, Loukman Omarjee et al.

Diabetes and Vascular Disease Research, 2019, 16 (1), pp.108.

DOI : https://doi.org/10.1177/1479164118809527

Pubmed : 30426760

 

94 - 

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

David-Axel Laplaud, Romain Casey, Laetitia Barbin, Marc Debouverie, Jerome de Sèze et al.

Neurology, 2019, 93 (7), pp.e635-e646.

DOI : https://doi.org/10.1212/WNL.0000000000007938

Pubmed : 31300547

 

95 - 

Risk factors of frailty and death or only frailty after intensive care in non-frail elderly patients a prospective non-interventional study

Yoann Launey, Hervé Jacquet, Matthieu Arnouat, Chloe Rousseau, Nicolas Nesseler et al.

Journal of Intensive Care, 2019, 7 (1), pp.48.

DOI : https://doi.org/10.1186/s40560-019-0403-3

Pubmed : 31687161

 

96 - 

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS

Caroline Lavie, Fabien Rollot, Françoise Durand-Dubief, Romain Marignier, Iuliana Ionescu et al.

Multiple Sclerosis Journal, 2019, 25 (4), pp.591-600.

DOI : https://doi.org/10.1177/1352458518763080

Pubmed : 31081475

 

97 - 

Apport de la génomique dans la médecine de demain, applications cliniques et enjeux

Bruno Laviolle, Olivier Perche, François Gueyffier, Élodie Bégué, Pascal Bilbault et al.

Thérapie, 2019, 74 (1), pp.1-8.

DOI : https://doi.org/10.1016/j.therap.2018.11.011

Pubmed : 30616902

 

98 - 

The contribution of genomics in the medicine of tomorrow, clinical applications and issues

Bruno Laviolle, Patrice Denèfle, François Gueyffier, Élodie Bégué, Pascal Bilbault et al.

Thérapie, 2019, 74 (1), pp.9-15.

DOI : https://doi.org/10.1016/j.therap.2018.11.012

Pubmed : 30638855

 

99 - 

Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE-CRT MPP-PHASE II)

Christophe Leclercq, Haran Burri, Antonio Curnis, Peter Paul Delnoy, Christopher A Rinaldi et al.

American Heart Journal, 2019, 209, pp.1-8.

DOI : https://doi.org/10.1016/j.ahj.2018.12.004

Pubmed : 30616009

 

100 - 

Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study results from Phase I

Christophe Leclercq, Haran Burri, Antonio Curnis, Peter Paul Delnoy, Christopher A Rinaldi et al.

European Heart Journal, 2019, 40 (35), pp.2979-2987.

DOI : https://doi.org/10.1093/eurheartj/ehz109

Pubmed : 30859220